Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / April / Japan Debuts Novel Dry Eye Therapy
Cornea Health Economics and Policy Latest News

Japan Debuts Novel Dry Eye Therapy

Senju Pharmaceutical launches the first TRPV1 antagonist for dry eye in Japan

4/30/2026 2 min read

Share

  • Full Article
  • Summary
  • Listen
  • Report
  • Poll
  • Top Institutions
Top Institutions in Ophthalmology

Based on known institutional expertise and research leadership in ophthalmology, ocular surface disease, and clinical trials in dry eye disease, institutions with strong programs in ocular inflammation, neuro-ophthalmology, and translational research on novel therapeutic targets are prioritized.

  • #1

    Massachusetts Eye and Ear Infirmary

    Boston, MA

    Massachusetts Eye and Ear is a world leader in dry eye research and clinical trials, with extensive expertise in ocular surface inflammation and novel therapeutic development including neuro-modulatory targets.

    Key Differentiators

    • Ophthalmology
    • Ocular Surface Disease
    • Clinical Trials
  • #2

    Bascom Palmer Eye Institute, University of Miami

    Miami, FL

    Bascom Palmer is internationally recognized for its clinical and translational research in dry eye disease and ocular surface inflammation, with a strong focus on innovative treatment modalities.

    Key Differentiators

    • Ophthalmology
    • Cornea and External Disease
    • Translational Research
  • #3

    Johns Hopkins Wilmer Eye Institute

    Baltimore, MD

    Wilmer Eye Institute has a strong research portfolio in ocular surface disease and neuro-ophthalmology, contributing to understanding pain mechanisms relevant to TRPV1 antagonism in dry eye.

    Key Differentiators

    • Ophthalmology
    • Neuro-ophthalmology
    • Inflammation and Immunology
  • #4

    University of California, San Francisco (UCSF) Department of Ophthalmology

    San Francisco, CA

    UCSF has a robust clinical research program in dry eye disease and ocular surface inflammation, with expertise in novel drug development and patient-centered outcomes.

    Key Differentiators

    • Ophthalmology
    • Ocular Surface Disease
    • Clinical Research
  • #5

    Tokyo Medical University

    Tokyo, Tokyo Prefecture

    As a leading Japanese institution, Tokyo Medical University has contributed significantly to clinical research in dry eye disease and the development of novel therapies including TRPV1 antagonists.

    Key Differentiators

    • Ophthalmology
    • Clinical Trials
    • Pharmacology

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: